COMMUNIQUÉS West-GlobeNewswire

Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
06/08/2026
PURCHASE, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition [...]
Globus Medical Reports Second Quarter 2026 Results
06/08/2026
AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026. Second [...]
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
06/08/2026
Varsetatug masetecan (“Varseta-M”) Program: - Phase 1 monotherapy update in advanced colorectal cancer (CRC) expected by the end of 2026. Registrational study planned for initiation in 1H 2027 - - Phase 1 study in [...]
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
06/08/2026
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported [...]
Profound Medical Reports Second Quarter 2026 Financial Results
06/08/2026
– Operating expenses decline 16%, helping drive a 39% improvement in net loss – – Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing – – Strong clinical, commercial and [...]
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
06/08/2026
Record Second-Quarter Net Revenue Growth of 36% to $6 million; Core Programmatic Revenue Grew by 27% Year Over Year SOUTH ORANGE, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water [...]
TerrAscend Reports Second Quarter 2026 Financial Results
06/08/2026
Q2 2026 Net Revenue of $67.1 Million, Up Sequentially and Year-Over-Year Q2 2026 Gross Profit Margin of 54.0%, Up 120 Basis Points Sequentially and 290 Basis Points Year-Over-Year Q2 2026 Net Cash Provided from [...]
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
06/08/2026
- Duchenne (SGT-003): SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as of August 4, 2026 - - Solid expects to meet with the FDA in late Q4 2026 to [...]
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026
ZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential [...]
Oculis Reports Q2 2026 Financial Results and Provides Company Update
06/08/2026
Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following [...]
CVRx Reports Second Quarter 2026 Financial and Operating Results
06/08/2026
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Apyx Medical Corporation Reports Second Quarter 2026 Financial Results
06/08/2026
Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segment Successful limited launch of the power liposuction handpiece for the AYON platform [...]
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
06/08/2026
Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026 Initiated Phase 2b [...]
Maxim Hair Restoration Earns LegitScript Certification, Reinforcing Its Position as a Leading Hair Transplant Clinic
06/08/2026
Certification underscores Maxim's commitment to ethical and transparent practices in hair restoration services. New York City, NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration , a 15-location [...]
MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium
06/08/2026
First patients treated with agenT-797 were alive and afebrile at endpoint Day 28 with improved oxygenation, infection control and removal from ventilator and vasopressor support Analysis of blood and lung fluid showed [...]
Chemed Corporation Declares Quarterly Dividend of 70 Cents
06/08/2026
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE ) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, [...]
Genmab Announces Financial Results for the First Half of 2026
06/08/2026
August 6, 2026 Copenhagen, Denmark; Interim Report for the Six Months Ended June 30, 2026 Highlights Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide in patients with relapsed/refractory [...]
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
06/08/2026
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) ( [...]
ASHA To Present Its Annie Glenn Award To The Pitt
06/08/2026
TV Medical Drama Spotlights the Importance of Effective Communication Rockville, MD, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The Pitt , a popular and highly regarded TV series, will receive the American Speech-Language- [...]

Pages